SNOT-22 in a control population

S.E. Erskine, C. Hopkins, A. Clark, S. Anari, N. Kumar, A. Robertson, S. Sunkaraneni, J.A. Wilson, S. Carrie, N. Kara, J. Ray, R. Smith, C. Philpott, C. Philpott, S. Erskine, S. Morris, S. Ahmed, V. Sunkaraneni, P. Jervis, J. PanesaarA. Farboud, R. Cathcart, R. Almeyda, H. Khalil, P. Prinsley, N. Mansell, M. Salam, J. Hobson, J. Woods, E. Coombes

    Research output: Contribution to journalArticlepeer-review

    26 Citations (Scopus)

    Abstract

    Objectives
    To assess SNOT‐22 and its subscales in a non‐rhinosinusitis UK‐wide population.

    Design
    Self‐reported questionnaire.

    Setting
    Based from 30 ENT departments around the UK.

    Participants
    250 Non‐rhinosinusitis adults – no self‐reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months.

    Main outcome measures
    SNOT‐22, SF‐36.

    Results
    The mean SNOT‐22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5 and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains.

    Conclusions
    Our data demonstrate differences in SNOT‐22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis.
    Original languageEnglish
    Pages (from-to)81-85
    Number of pages5
    JournalClinical Otolaryngology
    Volume42
    Issue number1
    Early online date5 May 2017
    DOIs
    Publication statusE-pub ahead of print - 5 May 2017

    Fingerprint

    Dive into the research topics of 'SNOT-22 in a control population'. Together they form a unique fingerprint.

    Cite this